EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Buspirone combats cyclophosphamide-provoked hepatotoxicity in rats via activation of AMPK/Nrf2/HO-1 and suppression of NF-κB p65 /NLRP3 inflammasome pathways

Marwa M Khalaf, Ehab E Sharata, Waleed A I Khallaf, Mina Ezzat Attya, Amira M Abo-Youssef, Ramadan A M Hemeida, Remon Roshdy Rofaeil

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-02 · 399 (4) · 5483-5498

DOI: 10.1007/s00210-025-04718-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 03.11.2025. Verfasst von Marwa M Khalaf und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Cyclophosphamide. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deraya University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to evaluate the protective effect of buspirone (BUS) against liver damage caused by cyclophosphamide (CPA) by focusing on the α-klotho/Nrf2/HO-1 and AMPK/NF-κB p65/NLRP3/caspase-1 signaling cascades. The possible damage that CPA might produce was evaluated using histological examination in conjunction with serum AST, ALT, and direct bilirubin. GSH and MDA levels were measured using a colorimetric technique. TNF-α, IL-1β, and IL-18 levels, as well as hepatic caspase-1, hepatic p-AMPK, and serum α-klotho, were measured using the ELISA technique. Using an immunohistochemistry method, the Nrf2 and caspase-3 expression in the liver tissue was investigated. The expression of HO-1 mRNA was assessed by means of RT-qPCR. The expression levels of NF-κB p65 and NLRP3 were assessed by western blotting. BUS, in a dose-dependent manner, attenuated CPA-induced hepatotoxicity by reducing the elevated serum AST, ALT, and direct bilirubin and alleviating the histopathological aberrations. Additionally, it raised GSH levels and decreased MDA levels. In addition, it reduced levels of inflammatory markers and caspase-3 expression. BUS also increased p-AMPK and α-klotho protein levels and stimulated the production of Nrf2 and HO-1. Additionally, it reduced pyroptosis by downregulating NLRP3 and caspase-1 expression levels. BUS attenuated NF-κB p65/NLRP3 inflammasome and caspase-3-mediated apoptotic activity and enhanced Nrf2/HO-1 activity, therefore mitigating the liver impairment provoked by CPA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemical and Drug Induced Liver InjuryCyclophosphamideAnimalsNLR Family, Pyrin Domain-Containing 3 ProteinNF-E2-Related Factor 2MaleInflammasomesAMP-Activated Protein KinasesSignal TransductionRatsTranscription Factor RelALiverHeme Oxygenase (Decyclizing)Rats, Sprague-DawleyMembrane Proteins

Stichwörter der Autor:innen

BuspironeCyclophosphamideHepatic injuryNLRP3Nrf2α-Klotho

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinNF-E2-Related Factor 2InflammasomesNfe2l2 protein, ratHmox1 protein, ratNlrp3 protein, ratAMP-Activated Protein KinasesCyclophosphamideTranscription Factor RelAHeme Oxygenase (Decyclizing)

Autor:innen und Institutionen

  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt.
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Deraya University, Minia, 61111, Egypt. ehab.essam@deraya.edu.eg.
  • Department of Pathology, Faculty of Medicine, Minia University, Minia, 61519, Egypt.
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Deraya University, Minia, 61111, Egypt.
  • Department of Medical Pharmacology, Faculty of Medicine, Minia University, Minia, 61519, Egypt.

Förderung

  • Deraya University

Zitieren

APA

Khalaf, M. M., Sharata, E. E., Khallaf, W. A. I., Attya, M. E., Abo-Youssef, A. M., Hemeida, R. A. M., & Rofaeil, R. R. (2026). Buspirone combats cyclophosphamide-provoked hepatotoxicity in rats via activation of AMPK/Nrf2/HO-1 and suppression of NF-κB p65 /NLRP3 inflammasome pathways. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(4), 5483-5498. https://doi.org/10.1007/s00210-025-04718-3

Vancouver

Khalaf MM, Sharata EE, Khallaf WAI, Attya ME, Abo-Youssef AM, Hemeida RAM, et al. Buspirone combats cyclophosphamide-provoked hepatotoxicity in rats via activation of AMPK/Nrf2/HO-1 and suppression of NF-κB p65 /NLRP3 inflammasome pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(4):5483-5498. doi:10.1007/s00210-025-04718-3

BibTeX
@article{Khalaf2026,
  author = {Khalaf, Marwa M and Sharata, Ehab E and Khallaf, Waleed A I and Attya, Mina Ezzat and Abo-Youssef, Amira M and Hemeida, Ramadan A M and Rofaeil, Remon Roshdy},
  title = {Buspirone combats cyclophosphamide-provoked hepatotoxicity in rats via activation of AMPK/Nrf2/HO-1 and suppression of NF-κB p65 /NLRP3 inflammasome pathways},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {4},
  pages = {5483--5498},
  doi = {10.1007/s00210-025-04718-3}
}
Kostenlos starten →